Sydney A. Gilman

Insider Reports History

Location
Minneapolis, MN
Signature
/s/ Amy Culbert, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sydney A. Gilman:

Company Role Class Num Shares Value Price $ Report Date Ownership
DiaMedica Therapeutics Inc. VP, Regulatory Affairs Stock Option (right to buy) 25,000 28 Jul 2021 Direct
DiaMedica Therapeutics Inc. VP, Regulatory Affairs Voting Common Shares, no par value per share 0 $2.80 28 Jul 2021 Direct

Insider Reports Filed by Sydney A. Gilman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DMAC DiaMedica Therapeutics Inc. 28 Jul 2021 1 $0 4 VP, Regulatory Affairs 29 Jul 2021, 21:18